OTC Pharmaceuticals - EU-27

EU-27

In 2024, the revenue in the OTC Pharmaceuticals market in EU-15.95% amounts to US$38.56bn.
It is projected to grow annually by 3.88% (CAGR 2024-2029).
The largest market in this market is Other OTC Pharmaceuticals, with a market volume of US$11.52bn in 2024.
When compared globally, the in the United States generates the highest revenue, amounting to US$41,240.00m in 2024.
In terms of per capita revenue, each person in EU-15.95% generates US$86.16 in 2024.
Online sales are expected to contribute 15.95% of the total revenue in the OTC Pharmaceuticals market by 2024.
Germany's OTC pharmaceutical market is driven by a strong demand for natural remedies and herbal supplements.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in EU-27 is experiencing steady growth due to various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the EU-27 region play a significant role in the development of the OTC Pharmaceuticals market. Consumers in this region are increasingly seeking convenience and cost-effectiveness in their healthcare choices. They prefer self-medication for minor ailments and are more inclined towards purchasing over-the-counter (OTC) medicines without a prescription. This preference for OTC medicines is driven by factors such as ease of access, affordability, and the ability to self-diagnose and treat common health conditions.Trends in the market also contribute to the growth of the OTC Pharmaceuticals market in the EU-27 region. One notable trend is the increasing focus on preventive healthcare and wellness. Consumers are becoming more proactive in managing their health and are willing to invest in OTC products that promote overall well-being. This trend is supported by the availability of a wide range of OTC products that cater to different health needs, including vitamins, dietary supplements, and natural remedies.Another trend in the market is the growing popularity of online and e-commerce platforms for purchasing OTC medicines. The convenience of online shopping, coupled with the availability of a vast selection of products, has attracted a significant number of consumers in the EU-27 region. Online platforms also provide customers with the opportunity to compare prices, read reviews, and access information about the products, further influencing their purchasing decisions.Local special circumstances in the EU-27 region also contribute to the development of the OTC Pharmaceuticals market. The presence of a well-established healthcare infrastructure and regulatory framework ensures the safety and quality of OTC medicines. Additionally, the high level of consumer awareness and education regarding self-care and responsible medication use further drives the demand for OTC products.Underlying macroeconomic factors, such as increasing disposable income and changing demographics, also play a role in the growth of the OTC Pharmaceuticals market in the EU-27 region. As disposable income levels rise, consumers have more purchasing power to spend on healthcare products. Furthermore, the aging population in many EU-27 countries creates a growing demand for OTC medicines to manage age-related health conditions.In conclusion, the OTC Pharmaceuticals market in the EU-27 region is developing steadily due to customer preferences for convenience and cost-effectiveness, trends in the market such as preventive healthcare and online shopping, local special circumstances such as a well-established healthcare infrastructure, and underlying macroeconomic factors including increasing disposable income and changing demographics. These factors collectively contribute to the growth and expansion of the OTC Pharmaceuticals market in the EU-27 region.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.